A preinvasive regulatory T cell axis for lung cancer interception - Nature
NatureOctober 7, 2026
An effector regulatory T cell circuit is identified that can be monitored in blood samples to track the development of lung cancer, and blockade of this immune network in the preinvasive setting can intercept tumorigenesis to reduce tumour incidence…
Where this sits on TrendsMap
This story hasn’t been tied to a specific state or province yet — it sits in our United States coverage. We hold 1047 health stories in total, and 51 from Nature.
This is a summary of reporting by Nature. Read the full story at the source.
Read full storyPredictions (0)
No predictions yet on this story — be the first to start one.
Comments (0)
GU
posting as a guest
Create a free account to comment under your own name and earn Pulse.